The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Wilson Martin | General Counsel | Sell(S) | 1K | $3.34 | $5K |
| Feb 18, 2026 | Shah Gaurav | CEO | Sell(S) | 6K | $3.34 | $20K |
| Feb 18, 2026 | Militello John | See Remarks | Sell(S) | 1K | $3.34 | $4K |
| Feb 13, 2026 | Shah Gaurav | CEO | Sell(S) | 12K | $3.31 | $41K |
| Feb 13, 2026 | Militello John | See Remarks | Sell(S) | 4K | $3.31 | $12K |
| Feb 13, 2026 | Wilson Martin | General Counsel | Sell(S) | 12K | $3.31 | $41K |
| Feb 11, 2026 | Chaudhuri Sarbani | See Remarks | Grant(A) | 126K | — | $0 |
| Feb 11, 2026 | Chaudhuri Sarbani | See Remarks | Grant(A) | 189K | — | $0 |
| Feb 11, 2026 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 62K | — | $0 |
| Feb 11, 2026 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 93K | — | $0 |
| Feb 11, 2026 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 62K | — | $0 |
| Feb 11, 2026 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 93K | — | $0 |
| Feb 11, 2026 | Wilson Martin | General Counsel | Grant(A) | 312K | — | $0 |
| Feb 11, 2026 | Wilson Martin | General Counsel | Grant(A) | 468K | — | $0 |
| Feb 11, 2026 | Militello John | See Remarks | Grant(A) | 30K | — | $0 |
| Feb 11, 2026 | Militello John | See Remarks | Grant(A) | 45K | — | $0 |
| Feb 11, 2026 | Shah Gaurav | CEO | Grant(A) | 286K | — | $0 |
| Feb 11, 2026 | Shah Gaurav | CEO | Grant(A) | 871K | — | $0 |
| Jan 2, 2026 | Bjork Elisabeth | Director | Buy(P) | 10K | $3.44 | $34K |
| Nov 18, 2025 | Wilson Martin | General Counsel | Sell(S) | 2K | $2.98 | $5K |
| Nov 18, 2025 | Shah Gaurav | CEO, Director | Sell(S) | 6K | $2.98 | $19K |
| Nov 18, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 3K | $2.98 | $8K |
| Nov 18, 2025 | Militello John | See Remarks | Sell(S) | 1K | $2.98 | $3K |
| Nov 3, 2025 | Wilson Martin | General Counsel | Grant(A) | 100K | — | $0 |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 20K | $3.96 | $79K |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 558 | $3.98 | $2K |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 3K | $3.97 | $12K |
| Oct 14, 2025 | Militello John | See Remarks | Sell(S) | 6K | $3.97 | $22K |
| Oct 6, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Oct 6, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 283K | — | $0 |
| Oct 6, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 384K | — | $0 |
| Sep 24, 2025 | Fong Peter | Director | Grant(A) | 23K | — | $0 |
| Sep 24, 2025 | Fong Peter | Director | Grant(A) | 30K | — | $0 |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Other(J) | 59K | $3.11 | $183K |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1.0M | $40.03 | $40.0M |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Other(J) | 1.0M | $3.11 | $3.1M |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 41K | $19.09 | $783K |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Other(J) | 41K | $3.11 | $128K |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 59K | $17.81 | $1.1M |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1 | — | — |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1 | — | — |
| Sep 19, 2025 | RTW Investments, LP | Director, 10% Owner | Option exercise(X) | 1 | — | — |
| Sep 8, 2025 | Schwartz Jonathan David | See Remarks | Grant(A) | 80K | — | $0 |
| Sep 8, 2025 | Wilson Martin | General Counsel | Grant(A) | 150K | — | $0 |
| Sep 8, 2025 | Militello John | See Remarks | Grant(A) | 40K | — | $0 |
| Aug 27, 2025 | Bjork Elisabeth | Director | Buy(P) | 10K | $3.41 | $34K |
| Aug 19, 2025 | Wilson Martin | General Counsel | Sell(S) | 588 | $3.00 | $2K |
| Aug 19, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 805 | $3.00 | $2K |
| Aug 19, 2025 | Militello John | See Remarks | Sell(S) | 361 | $3.00 | $1K |
| Aug 18, 2025 | Shah Gaurav | CEO, Director | Tax withholding(F) | 2K | $3.05 | $7K |
| Aug 18, 2025 | Wilson Martin | General Counsel | Sell(S) | 1K | $3.07 | $3K |
| Aug 18, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 2K | $3.07 | $5K |
| Aug 18, 2025 | Militello John | See Remarks | Sell(S) | 699 | $3.07 | $2K |
| Aug 14, 2025 | Wilson Martin | General Counsel | Sell(S) | 12K | $3.02 | $37K |
| Aug 14, 2025 | Militello John | See Remarks | Sell(S) | 7K | $3.02 | $21K |
| Aug 14, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 11K | $3.02 | $34K |
| Aug 4, 2025 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 407K | — | $0 |
| Aug 4, 2025 | Stevens Christopher James | Chief Operating Officer | Grant(A) | 554K | — | $0 |
| Jul 3, 2025 | Ondrey Aaron | Chief Financial Officer | Sell(S) | 1K | $2.88 | $4K |
| Jun 18, 2025 | Southwell David P | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Bjork Elisabeth | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Boess Carsten | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Malik Fady Ibraham | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Makker Gotham | Director | Grant(A) | 19K | — | $0 |
| Jun 18, 2025 | Makker Gotham | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Dolsten Mikael | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Granadillo Pedro P | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Granadillo Pedro P | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Pratumsuwan Piratip | Director | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Wong Roderick | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Jun 18, 2025 | Wong Roderick | Director, 10% Owner | Grant(A) | 18K | — | $0 |
| May 20, 2025 | Wilson Martin | General Counsel | Sell(S) | 587 | $6.45 | $4K |
| May 20, 2025 | Shah Gaurav | CEO, Director | Sell(S) | 2K | $6.45 | $15K |
| May 20, 2025 | Patel Kinnari | See Remarks | Sell(S) | 767 | $6.45 | $5K |
| May 20, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 801 | $6.45 | $5K |
| May 20, 2025 | Militello John | See Remarks | Sell(S) | 357 | $6.45 | $2K |
| May 16, 2025 | Wilson Martin | General Counsel | Sell(S) | 946 | $6.53 | $6K |
| May 16, 2025 | Shah Gaurav | CEO, Director | Sell(S) | 4K | $6.53 | $24K |
| May 16, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 2K | $6.53 | $10K |
| May 16, 2025 | Patel Kinnari | See Remarks | Sell(S) | 1K | $6.53 | $9K |
| May 16, 2025 | Militello John | See Remarks | Sell(S) | 655 | $6.53 | $4K |
| Apr 22, 2025 | Militello John | See Remarks | Sell(S) | 718 | $7.16 | $5K |
| Apr 10, 2025 | Shah Gaurav | CEO, Director | Buy(P) | 20K | $5.08 | $102K |
| Apr 9, 2025 | Patel Kinnari | See Remarks | Buy(P) | 21K | $4.70 | $99K |
| Apr 4, 2025 | Ondrey Aaron | Chief Financial Officer | Sell(S) | 7K | $5.29 | $40K |
| Mar 5, 2025 | Dolsten Mikael | Director | Other(J) | 14K | — | $0 |
| Feb 25, 2025 | Schwartz Jonathan David | See Remarks | Sell(S) | 7K | $10.58 | $69K |
| Feb 21, 2025 | Shah Gaurav | CEO, Director | Sell(S) | 16K | $10.58 | $172K |
| Feb 21, 2025 | Militello John | See Remarks | Sell(S) | 3K | $10.58 | $29K |
| Feb 21, 2025 | Wilson Martin | General Counsel | Sell(S) | 3K | $10.58 | $34K |
| Feb 21, 2025 | Patel Kinnari | See Remarks | Sell(S) | 6K | $10.58 | $64K |
| Feb 11, 2025 | Militello John | See Remarks | Grant(A) | 20K | — | $0 |
| Feb 11, 2025 | Militello John | See Remarks | Grant(A) | 30K | — | $0 |
| Feb 11, 2025 | Ondrey Aaron | Chief Financial Officer | Grant(A) | 90K | — | $0 |
| Feb 11, 2025 | Ondrey Aaron | Chief Financial Officer | Grant(A) | 135K | — | $0 |
| Feb 11, 2025 | Patel Kinnari | See Remarks | Grant(A) | 58K | — | $0 |
| Feb 11, 2025 | Patel Kinnari | See Remarks | Grant(A) | 172K | — | $0 |
| Feb 11, 2025 | Schwartz Jonathan David | See Remarks | Grant(A) | 80K | — | $0 |
| Feb 11, 2025 | Schwartz Jonathan David | See Remarks | Grant(A) | 120K | — | $0 |
| Feb 11, 2025 | Shah Gaurav | CEO, Director | Grant(A) | 82K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).